Initiation of human immunodeficiency virus preexposure prophylaxis (PrEP) medications will also treat hepatitis B infection (HBV). The prevalence of chronic HBV was 0.86% (n=41/4760) among enrollees in a provincial PrEP program in British Columbia, Canada. Overall, 46.3% lacked follow-up HBV DNA monitoring, underscoring the need for HBV-related education for PrEP prescribers.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598915 | PMC |
| http://dx.doi.org/10.1093/ofid/ofab492 | DOI Listing |
Publication Analysis
Top Keywords
hepatitis infection
8
preexposure prophylaxis
8
program british
8
british columbia
8
columbia canada
8
chronic hepatitis
4
infection preexposure
4
prophylaxis users
4
users enrolled
4
enrolled population-based
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!